Table of Contents Executive Summary 1 Industry Overview of Systemic Lupus Erythematous SLE Drug 1.1 Definition of Systemic Lupus Erythematous SLE Drug 1.2 Systemic Lupus Erythematous SLE Drug Segment by Type 1.2.1 Global Systemic Lupus Erythematous SLE Drug Production Growth Rate Comparison by Types (2014-2025) 1.2.2 Corticosteroids 1.2.3 Non-Steroidal Anti-inflammatory Drugs (NSAIDs) 1.2.4 Anti-Inflammatories 1.2.5 Disease-Modifying Anti-Rheumatic Drugs (DMARDs) 1.2.6 Antimalarials 1.2.7 BLyS-specific Inhibitors or Monoclonal Antibodies (MAbS) 1.2.8 Immunosuppressive Agents/Immune Modulators 1.2.9 Anticoagulants 1.3 Systemic Lupus Erythematous SLE Drug Segment by Applications 1.3.1 Global Systemic Lupus Erythematous SLE Drug Consumption Comparison by Applications (2014-2025) 1.3.2 Hospitals 1.3.3 Hospital Pharmacies 1.3.4 Drug Stores 1.3.5 Online Drug Stores 1.4 Global Systemic Lupus Erythematous SLE Drug Overall Market 1.4.1 Global Systemic Lupus Erythematous SLE Drug Revenue (2014-2025) 1.4.2 Global Systemic Lupus Erythematous SLE Drug Production (2014-2025) 1.4.3 North America Systemic Lupus Erythematous SLE Drug Status and Prospect (2014-2025) 1.4.4 Europe Systemic Lupus Erythematous SLE Drug Status and Prospect (2014-2025) 1.4.5 China Systemic Lupus Erythematous SLE Drug Status and Prospect (2014-2025) 1.4.6 Japan Systemic Lupus Erythematous SLE Drug Status and Prospect (2014-2025) 1.4.7 Southeast Asia Systemic Lupus Erythematous SLE Drug Status and Prospect (2014-2025) 1.4.8 India Systemic Lupus Erythematous SLE Drug Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Systemic Lupus Erythematous SLE Drug 2.3 Manufacturing Process Analysis of Systemic Lupus Erythematous SLE Drug 2.4 Industry Chain Structure of Systemic Lupus Erythematous SLE Drug 3 Development and Manufacturing Plants Analysis of Systemic Lupus Erythematous SLE Drug 3.1 Capacity and Commercial Production Date 3.2 Global Systemic Lupus Erythematous SLE Drug Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of Systemic Lupus Erythematous SLE Drug 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 Systemic Lupus Erythematous SLE Drug Production and Capacity Analysis 4.2 Systemic Lupus Erythematous SLE Drug Revenue Analysis 4.3 Systemic Lupus Erythematous SLE Drug Price Analysis 4.4 Market Concentration Degree 5 Systemic Lupus Erythematous SLE Drug Regional Market Analysis 5.1 Systemic Lupus Erythematous SLE Drug Production by Regions 5.1.1 Global Systemic Lupus Erythematous SLE Drug Production by Regions 5.1.2 Global Systemic Lupus Erythematous SLE Drug Revenue by Regions 5.2 Systemic Lupus Erythematous SLE Drug Consumption by Regions 5.3 North America Systemic Lupus Erythematous SLE Drug Market Analysis 5.3.1 North America Systemic Lupus Erythematous SLE Drug Production 5.3.2 North America Systemic Lupus Erythematous SLE Drug Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America Systemic Lupus Erythematous SLE Drug Import and Export 5.4 Europe Systemic Lupus Erythematous SLE Drug Market Analysis 5.4.1 Europe Systemic Lupus Erythematous SLE Drug Production 5.4.2 Europe Systemic Lupus Erythematous SLE Drug Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe Systemic Lupus Erythematous SLE Drug Import and Export 5.5 China Systemic Lupus Erythematous SLE Drug Market Analysis 5.5.1 China Systemic Lupus Erythematous SLE Drug Production 5.5.2 China Systemic Lupus Erythematous SLE Drug Revenue 5.5.3 Key Manufacturers in China 5.5.4 China Systemic Lupus Erythematous SLE Drug Import and Export 5.6 Japan Systemic Lupus Erythematous SLE Drug Market Analysis 5.6.1 Japan Systemic Lupus Erythematous SLE Drug Production 5.6.2 Japan Systemic Lupus Erythematous SLE Drug Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan Systemic Lupus Erythematous SLE Drug Import and Export 5.7 Southeast Asia Systemic Lupus Erythematous SLE Drug Market Analysis 5.7.1 Southeast Asia Systemic Lupus Erythematous SLE Drug Production 5.7.2 Southeast Asia Systemic Lupus Erythematous SLE Drug Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia Systemic Lupus Erythematous SLE Drug Import and Export 5.8 India Systemic Lupus Erythematous SLE Drug Market Analysis 5.8.1 India Systemic Lupus Erythematous SLE Drug Production 5.8.2 India Systemic Lupus Erythematous SLE Drug Revenue 5.8.3 Key Manufacturers in India 5.8.4 India Systemic Lupus Erythematous SLE Drug Import and Export 6 Systemic Lupus Erythematous SLE Drug Segment Market Analysis (by Type) 6.1 Global Systemic Lupus Erythematous SLE Drug Production by Type 6.2 Global Systemic Lupus Erythematous SLE Drug Revenue by Type 6.3 Systemic Lupus Erythematous SLE Drug Price by Type 7 Systemic Lupus Erythematous SLE Drug Segment Market Analysis (by Application) 7.1 Global Systemic Lupus Erythematous SLE Drug Consumption by Application 7.2 Global Systemic Lupus Erythematous SLE Drug Consumption Market Share by Application (2014-2019) 8 Systemic Lupus Erythematous SLE Drug Major Manufacturers Analysis 8.1 Anthera Pharmaceuticals BMS 8.1.1 Anthera Pharmaceuticals BMS Systemic Lupus Erythematous SLE Drug Production Sites and Area Served 8.1.2 Anthera Pharmaceuticals BMS Product Introduction, Application and Specification 8.1.3 Anthera Pharmaceuticals BMS Systemic Lupus Erythematous SLE Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 GSK 8.2.1 GSK Systemic Lupus Erythematous SLE Drug Production Sites and Area Served 8.2.2 GSK Product Introduction, Application and Specification 8.2.3 GSK Systemic Lupus Erythematous SLE Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 ImmuPharma 8.3.1 ImmuPharma Systemic Lupus Erythematous SLE Drug Production Sites and Area Served 8.3.2 ImmuPharma Product Introduction, Application and Specification 8.3.3 ImmuPharma Systemic Lupus Erythematous SLE Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 8.4 Merck Serono 8.4.1 Merck Serono Systemic Lupus Erythematous SLE Drug Production Sites and Area Served 8.4.2 Merck Serono Product Introduction, Application and Specification 8.4.3 Merck Serono Systemic Lupus Erythematous SLE Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.4.4 Main Business and Markets Served 8.5 UCB 8.5.1 UCB Systemic Lupus Erythematous SLE Drug Production Sites and Area Served 8.5.2 UCB Product Introduction, Application and Specification 8.5.3 UCB Systemic Lupus Erythematous SLE Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.5.4 Main Business and Markets Served 8.6 Amgen 8.6.1 Amgen Systemic Lupus Erythematous SLE Drug Production Sites and Area Served 8.6.2 Amgen Product Introduction, Application and Specification 8.6.3 Amgen Systemic Lupus Erythematous SLE Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.6.4 Main Business and Markets Served 8.7 HGS 8.7.1 HGS Systemic Lupus Erythematous SLE Drug Production Sites and Area Served 8.7.2 HGS Product Introduction, Application and Specification 8.7.3 HGS Systemic Lupus Erythematous SLE Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.7.4 Main Business and Markets Served 8.8 Immunomedics 8.8.1 Immunomedics Systemic Lupus Erythematous SLE Drug Production Sites and Area Served 8.8.2 Immunomedics Product Introduction, Application and Specification 8.8.3 Immunomedics Systemic Lupus Erythematous SLE Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.8.4 Main Business and Markets Served 8.9 MedImmune 8.9.1 MedImmune Systemic Lupus Erythematous SLE Drug Production Sites and Area Served 8.9.2 MedImmune Product Introduction, Application and Specification 8.9.3 MedImmune Systemic Lupus Erythematous SLE Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.9.4 Main Business and Markets Served 8.10 Sanofi 8.10.1 Sanofi Systemic Lupus Erythematous SLE Drug Production Sites and Area Served 8.10.2 Sanofi Product Introduction, Application and Specification 8.10.3 Sanofi Systemic Lupus Erythematous SLE Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.10.4 Main Business and Markets Served 9 Development Trend of Analysis of Systemic Lupus Erythematous SLE Drug Market 9.1 Global Systemic Lupus Erythematous SLE Drug Market Trend Analysis 9.1.1 Global Systemic Lupus Erythematous SLE Drug Market Size (Volume and Value) Forecast 2019-2025 9.2 Systemic Lupus Erythematous SLE Drug Regional Market Trend 9.2.1 North America Systemic Lupus Erythematous SLE Drug Forecast 2019-2025 9.2.2 Europe Systemic Lupus Erythematous SLE Drug Forecast 2019-2025 9.2.3 China Systemic Lupus Erythematous SLE Drug Forecast 2019-2025 9.2.4 Japan Systemic Lupus Erythematous SLE Drug Forecast 2019-2025 9.2.5 Southeast Asia Systemic Lupus Erythematous SLE Drug Forecast 2019-2025 9.2.6 India Systemic Lupus Erythematous SLE Drug Forecast 2019-2025 9.3 Systemic Lupus Erythematous SLE Drug Market Trend (Product Type) 9.4 Systemic Lupus Erythematous SLE Drug Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 Systemic Lupus Erythematous SLE Drug Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of Systemic Lupus Erythematous SLE Drug Table Global Systemic Lupus Erythematous SLE Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025) Figure Global Systemic Lupus Erythematous SLE Drug Production Market Share by Types in 2018 Figure Corticosteroids Product Picture Figure Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Product Picture Figure Anti-Inflammatories Product Picture Figure Disease-Modifying Anti-Rheumatic Drugs (DMARDs) Product Picture Figure Antimalarials Product Picture Figure BLyS-specific Inhibitors or Monoclonal Antibodies (MAbS) Product Picture Figure Immunosuppressive Agents/Immune Modulators Product Picture Figure Anticoagulants Product Picture Table Global Systemic Lupus Erythematous SLE Drug Consumption (K Pcs) Comparison by Applications (2014-2025) Figure Global Systemic Lupus Erythematous SLE Drug Consumption Market Share by Applications in 2018 Figure Hospitals Figure Hospital Pharmacies Figure Drug Stores Figure Online Drug Stores Figure Global Systemic Lupus Erythematous SLE Drug Revenue (Million USD) (2014-2025) Figure Global Systemic Lupus Erythematous SLE Drug Production (K Pcs) (2014-2025) Figure North America Systemic Lupus Erythematous SLE Drug Market Size (Million USD) (2014-2025) Figure Europe Systemic Lupus Erythematous SLE Drug Market Size (Million USD) (2014-2025) Figure China Systemic Lupus Erythematous SLE Drug Market Size (Million USD) (2014-2025) Figure Japan Systemic Lupus Erythematous SLE Drug Market Size (Million USD) (2014-2025) Figure Southeast Asia Systemic Lupus Erythematous SLE Drug Market Size (Million USD) (2014-2025) Figure India Systemic Lupus Erythematous SLE Drug Market Size (Million USD) (2014-2025) Table Systemic Lupus Erythematous SLE Drug Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of Systemic Lupus Erythematous SLE Drug in 2018 Figure Manufacturing Process Analysis of Systemic Lupus Erythematous SLE Drug Figure Industry Chain Structure of Systemic Lupus Erythematous SLE Drug Table Capacity and Commercial Production Date of Key Manufacturers Table Global Systemic Lupus Erythematous SLE Drug Manufacturing Plants Distribution Table Systemic Lupus Erythematous SLE Drug Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table Systemic Lupus Erythematous SLE Drug Capacity (K Pcs) of Major Manufacturers (2014-2019) Table Systemic Lupus Erythematous SLE Drug Production (K Pcs) of Major Manufacturers (2014-2019) Table Systemic Lupus Erythematous SLE Drug Production Market Share of Major Manufacturers (2014-2019) Figure Systemic Lupus Erythematous SLE Drug Production Share by Manufacturers in 2018 Table Systemic Lupus Erythematous SLE Drug Revenue (Million US$) of Major Manufacturers (2014-2019) Table Systemic Lupus Erythematous SLE Drug Revenue Market Share of Major Manufacturers (2014-2019) Figure Systemic Lupus Erythematous SLE Drug Revenue Share by Manufacturers in 2018 Table Systemic Lupus Erythematous SLE Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global Systemic Lupus Erythematous SLE Drug Production by Regions 2014-2019 (K Pcs) Table Global Systemic Lupus Erythematous SLE Drug Production Market Share by Regions 2014-2019 Figure Global Systemic Lupus Erythematous SLE Drug Production Market Share by Regions in 2018 Table Global Systemic Lupus Erythematous SLE Drug Revenue by Regions 2014-2019 (Million USD) Table Global Systemic Lupus Erythematous SLE Drug Revenue Market Share by Regions 2014-2019 Figure Global Systemic Lupus Erythematous SLE Drug Revenue Market Share by Regions in 2018 Table Global Systemic Lupus Erythematous SLE Drug Consumption by Regions 2014-2019 (K Pcs) Table Global Systemic Lupus Erythematous SLE Drug Consumption Market Share by Regions 2014-2019 Figure North America Systemic Lupus Erythematous SLE Drug Production Growth Rate 2014-2019 (K Pcs) Figure North America Systemic Lupus Erythematous SLE Drug Revenue Growth Rate 2014-2019 (Million USD) Table North America Systemic Lupus Erythematous SLE Drug Production, Consumption Import and Export (K Pcs) Figure Europe Systemic Lupus Erythematous SLE Drug Production Growth Rate 2014-2019 (K Pcs) Figure Europe Systemic Lupus Erythematous SLE Drug Revenue Growth Rate 2014-2019 (Million USD) Table Europe Systemic Lupus Erythematous SLE Drug Production, Consumption Import and Export (K Pcs) Figure China Systemic Lupus Erythematous SLE Drug Production Growth Rate 2014-2019 (K Pcs) Figure China Systemic Lupus Erythematous SLE Drug Revenue Growth Rate 2014-2019 (Million USD) Table China Systemic Lupus Erythematous SLE Drug Production, Consumption Import and Export (K Pcs) Figure Japan Systemic Lupus Erythematous SLE Drug Production Growth Rate 2014-2019 (K Pcs) Figure Japan Systemic Lupus Erythematous SLE Drug Revenue Growth Rate 2014-2019 (Million USD) Table Japan Systemic Lupus Erythematous SLE Drug Production, Consumption Import and Export (K Pcs) Figure Southeast Asia Systemic Lupus Erythematous SLE Drug Production Growth Rate 2014-2019 (K Pcs) Figure Southeast Asia Systemic Lupus Erythematous SLE Drug Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia Systemic Lupus Erythematous SLE Drug Production, Consumption Import and Export (K Pcs) Figure India Systemic Lupus Erythematous SLE Drug Production Growth Rate 2014-2019 (K Pcs) Figure India Systemic Lupus Erythematous SLE Drug Revenue Growth Rate 2014-2019 (Million USD) Table India Systemic Lupus Erythematous SLE Drug Production, Consumption Import and Export (K Pcs) Figure Global Consumption Systemic Lupus Erythematous SLE Drug Market Share by Application (2014-2019) Figure Global Value (Consumption) Systemic Lupus Erythematous SLE Drug Market Share by Application (2014-2019) Table Anthera Pharmaceuticals BMS Systemic Lupus Erythematous SLE Drug Production Sites and Area Served Table Anthera Pharmaceuticals BMS Systemic Lupus Erythematous SLE Drug Product Introduction, Application and Specification Table Anthera Pharmaceuticals BMS Systemic Lupus Erythematous SLE Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Anthera Pharmaceuticals BMS Systemic Lupus Erythematous SLE Drug Production Growth Rate (2014-2019) Table Anthera Pharmaceuticals BMS Systemic Lupus Erythematous SLE Drug Production Market Share (2014-2019) Figure Anthera Pharmaceuticals BMS Systemic Lupus Erythematous SLE Drug Revenue Market Share (2014-2019) Table Anthera Pharmaceuticals BMS Systemic Lupus Erythematous SLE Drug Main Business and Markets Served Table GSK Systemic Lupus Erythematous SLE Drug Production Sites and Area Served Table GSK Systemic Lupus Erythematous SLE Drug Product Introduction, Application and Specification Table GSK Systemic Lupus Erythematous SLE Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table GSK Systemic Lupus Erythematous SLE Drug Production Growth Rate (2014-2019) Table GSK Systemic Lupus Erythematous SLE Drug Production Market Share (2014-2019) Figure GSK Systemic Lupus Erythematous SLE Drug Revenue Market Share (2014-2019) Table GSK Systemic Lupus Erythematous SLE Drug Main Business and Markets Served Table ImmuPharma Systemic Lupus Erythematous SLE Drug Production Sites and Area Served Table ImmuPharma Systemic Lupus Erythematous SLE Drug Product Introduction, Application and Specification Table ImmuPharma Systemic Lupus Erythematous SLE Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table ImmuPharma Systemic Lupus Erythematous SLE Drug Production Growth Rate (2014-2019) Table ImmuPharma Systemic Lupus Erythematous SLE Drug Production Market Share (2014-2019) Figure ImmuPharma Systemic Lupus Erythematous SLE Drug Revenue Market Share (2014-2019) Table ImmuPharma Systemic Lupus Erythematous SLE Drug Main Business and Markets Served Table Merck Serono Systemic Lupus Erythematous SLE Drug Production Sites and Area Served Table Merck Serono Systemic Lupus Erythematous SLE Drug Product Introduction, Application and Specification Table Merck Serono Systemic Lupus Erythematous SLE Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Merck Serono Systemic Lupus Erythematous SLE Drug Production Growth Rate (2014-2019) Table Merck Serono Systemic Lupus Erythematous SLE Drug Production Market Share (2014-2019) Figure Merck Serono Systemic Lupus Erythematous SLE Drug Revenue Market Share (2014-2019) Table Merck Serono Systemic Lupus Erythematous SLE Drug Main Business and Markets Served Table UCB Systemic Lupus Erythematous SLE Drug Production Sites and Area Served Table UCB Systemic Lupus Erythematous SLE Drug Product Introduction, Application and Specification Table UCB Systemic Lupus Erythematous SLE Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table UCB Systemic Lupus Erythematous SLE Drug Production Growth Rate (2014-2019) Table UCB Systemic Lupus Erythematous SLE Drug Production Market Share (2014-2019) Figure UCB Systemic Lupus Erythematous SLE Drug Revenue Market Share (2014-2019) Table UCB Systemic Lupus Erythematous SLE Drug Main Business and Markets Served Table Amgen Systemic Lupus Erythematous SLE Drug Production Sites and Area Served Table Amgen Systemic Lupus Erythematous SLE Drug Product Introduction, Application and Specification Table Amgen Systemic Lupus Erythematous SLE Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Amgen Systemic Lupus Erythematous SLE Drug Production Growth Rate (2014-2019) Table Amgen Systemic Lupus Erythematous SLE Drug Production Market Share (2014-2019) Figure Amgen Systemic Lupus Erythematous SLE Drug Revenue Market Share (2014-2019) Table Amgen Systemic Lupus Erythematous SLE Drug Main Business and Markets Served Table HGS Systemic Lupus Erythematous SLE Drug Production Sites and Area Served Table HGS Systemic Lupus Erythematous SLE Drug Product Introduction, Application and Specification Table HGS Systemic Lupus Erythematous SLE Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table HGS Systemic Lupus Erythematous SLE Drug Production Growth Rate (2014-2019) Table HGS Systemic Lupus Erythematous SLE Drug Production Market Share (2014-2019) Figure HGS Systemic Lupus Erythematous SLE Drug Revenue Market Share (2014-2019) Table HGS Systemic Lupus Erythematous SLE Drug Main Business and Markets Served Table Immunomedics Systemic Lupus Erythematous SLE Drug Production Sites and Area Served Table Immunomedics Systemic Lupus Erythematous SLE Drug Product Introduction, Application and Specification Table Immunomedics Systemic Lupus Erythematous SLE Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Immunomedics Systemic Lupus Erythematous SLE Drug Production Growth Rate (2014-2019) Table Immunomedics Systemic Lupus Erythematous SLE Drug Production Market Share (2014-2019) Figure Immunomedics Systemic Lupus Erythematous SLE Drug Revenue Market Share (2014-2019) Table Immunomedics Systemic Lupus Erythematous SLE Drug Main Business and Markets Served Table MedImmune Systemic Lupus Erythematous SLE Drug Production Sites and Area Served Table MedImmune Systemic Lupus Erythematous SLE Drug Product Introduction, Application and Specification Table MedImmune Systemic Lupus Erythematous SLE Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table MedImmune Systemic Lupus Erythematous SLE Drug Production Growth Rate (2014-2019) Table MedImmune Systemic Lupus Erythematous SLE Drug Production Market Share (2014-2019) Figure MedImmune Systemic Lupus Erythematous SLE Drug Revenue Market Share (2014-2019) Table MedImmune Systemic Lupus Erythematous SLE Drug Main Business and Markets Served Table Sanofi Systemic Lupus Erythematous SLE Drug Production Sites and Area Served Table Sanofi Systemic Lupus Erythematous SLE Drug Product Introduction, Application and Specification Table Sanofi Systemic Lupus Erythematous SLE Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Sanofi Systemic Lupus Erythematous SLE Drug Production Growth Rate (2014-2019) Table Sanofi Systemic Lupus Erythematous SLE Drug Production Market Share (2014-2019) Figure Sanofi Systemic Lupus Erythematous SLE Drug Revenue Market Share (2014-2019) Table Sanofi Systemic Lupus Erythematous SLE Drug Main Business and Markets Served Figure Global Systemic Lupus Erythematous SLE Drug Production (K Pcs) Growth Rate Forecast 2019-2025 Figure Global Systemic Lupus Erythematous SLE Drug Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global Systemic Lupus Erythematous SLE Drug Sales Price (USD/Pcs) Forecast 2019-2025 Figure North America Systemic Lupus Erythematous SLE Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure North America Systemic Lupus Erythematous SLE Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe Systemic Lupus Erythematous SLE Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Europe Systemic Lupus Erythematous SLE Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China Systemic Lupus Erythematous SLE Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure China Systemic Lupus Erythematous SLE Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan Systemic Lupus Erythematous SLE Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Japan Systemic Lupus Erythematous SLE Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia Systemic Lupus Erythematous SLE Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Southeast Asia Systemic Lupus Erythematous SLE Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India Systemic Lupus Erythematous SLE Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure India Systemic Lupus Erythematous SLE Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (K Pcs) of Systemic Lupus Erythematous SLE Drug by Type (2019-2025) Table Global Consumption (K Pcs) of Systemic Lupus Erythematous SLE Drug by Application (2019-2025) Table Systemic Lupus Erythematous SLE Drug Distributors List Table Systemic Lupus Erythematous SLE Drug Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Anthera Pharmaceuticals BMS GSK ImmuPharma Merck Serono UCB Amgen HGS Immunomedics MedImmune Sanofi